Of the mice injected with selected B cell populations, 40% of B220+ and CD19+ injected mice developed lymphoma, but only 20% of those injected with CD93+ cells developed lymphoma and all of those injected with CD117+ cells or CD3+ control cells remained healthy (Additional file 1: Figure S5). This evidence concerns the gene CD93 and lymphoma.